SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995. It specializes in early-stage investments, focusing on deep technology innovations that address human and planetary health. The firm operates startup development programs, notably HAX and IndieBio, which provide resources, facilities, and lab equipment to accelerate the growth of promising startups. SOSV supports companies from their inception through various funding stages, including seed and series A rounds, while offering ongoing assistance to help them scale and attract additional investors. By concentrating on revolutionary technologies and cross-border markets, particularly in Asia, SOSV aims to foster significant advancements that benefit humanity and the environment.
BioLumen is a nutritional technology company that develops a patented dietary fiber technology platform that reduces the negative effect of a diet heavy in processed foods. BioLumen's technology is composed of insoluble dietary fiber matrix covered with a blend of food ingredients created from the latest drug delivery system research. The company's product, a nutraceutical, focuses on high risk individuals with prediabetes to help manage blood sugar levels, protect their liver from excess sugar and feed their gut microbiome, delivering health benefits. BioLumen was founded on 2018 and is headquartered in San Francisco, California.
Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels.
Sóliome is a Biotechnology company that develops protein-based sunscreens that are safe. The company was founded in 2021 and is based in San Francisco, California.
Sóliome is a Biotechnology company that develops protein-based sunscreens that are safe. The company was founded in 2021 and is based in San Francisco, California.
Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels.
Inso Biosciences is an early-stage biotechnology company developing hardware platforms and tools for genomic sample handling. Our patented microfluidic technology, invented and developed at Cornell University, performs high-efficiency processing of cellular material, and we are exploring applications in long-read DNA extraction, multiomic sample processing, and pathogen surveillance. To find out more, please visit our website: www.inso.bio To get in touch with us, please email: contact@inso.bio
Veloz Bio is a biotechnology company that uses molecular farming to create and manufacture animal-free and alternative proteins. The company was founded in 2021 and is based in Monterrey, Nuevo León.
Veloz Bio is a biotechnology company that uses molecular farming to create and manufacture animal-free and alternative proteins. The company was founded in 2021 and is based in Monterrey, Nuevo León.
Zymochem provides a carbon-efficient bio-manufacturing platform that converts renewable feedstocks into bio-based materials without compromising price, performance, scale, or sustainability while minimizing CO2 loss during production. It also accelerates a real-zero economy by relieving carbon emissions in product development, use, and end-of-life.
Prolific Machines is a biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future. It combines cutting-edge technologies to enable cell production at a new scale. The company was founded in 2020 and is based in San Francisco, California.
BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline of indications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.
Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.
Microgenesis offers a new fertility test and personalized nutritional supplementation that restores the fertility potential of women everywhere. Microgenesis has proven their validity in tough cases – women who have already failed multiple IVF implantations. Now, they are bringing their solution downmarket to OB-GYNs and D2C, operating out of a CLIA lab in Oakland. Microgenesis’ diagnostic detects subclinical inflammation that harms ovarian function and implantation. Their three-month treatment is drug-free and all-natural.
Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.
Intrinsic Medicine is a venture-backed, virtual, clinical-stage company with a technical and operational platform built to efficiently and ethically bring important medicines to patients.
Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels.
BiomeSense is developing the first technology platform for continuous, at-home monitoring of the human gut microbiome, transforming the ability to understand & utilize the microbiome for precision medicine. The enabling technology is the GutLab, the first “smart bathroom” system for at-home microbiome monitoring, which is combined with the MetaBiome time-series analytics platform into a single end-to-end solution. The platform allows scientists, patients, and consumers the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, revolutionizing the ability to leverage the microbiome for better health.
Prolific Machines is a biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future. It combines cutting-edge technologies to enable cell production at a new scale. The company was founded in 2020 and is based in San Francisco, California.
Wayfinder Biosciences is a biotechnology company developing orally available small molecule drugs that modulate the function of the RNAs encoding key disease targets. The company's proprietary platform combines unique screening and computational technologies to rapidly discover potent, selective and biologically active RNA-targeting small molecules. Wayfinder's programs are focused on traditionally inaccessible targets in oncology and neurodegenerative disease. Wayfinder Biosciences was established in 2021 and is headquartered in Seattle, WA.
Nyoka Design Labs leverages advances in clean tech to build inspiring, earth-friendly innovations. Starting with the Nyoka Light Wand, a non-toxic glow stick powered with bioluminescence, to prevent the billion toxic, single-use plastic glow sticks that enter our environment every single year.
Nyoka Design Labs leverages advances in clean tech to build inspiring, earth-friendly innovations. Starting with the Nyoka Light Wand, a non-toxic glow stick powered with bioluminescence, to prevent the billion toxic, single-use plastic glow sticks that enter our environment every single year.
Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.
Microgenesis offers a new fertility test and personalized nutritional supplementation that restores the fertility potential of women everywhere. Microgenesis has proven their validity in tough cases – women who have already failed multiple IVF implantations. Now, they are bringing their solution downmarket to OB-GYNs and D2C, operating out of a CLIA lab in Oakland. Microgenesis’ diagnostic detects subclinical inflammation that harms ovarian function and implantation. Their three-month treatment is drug-free and all-natural.
Biomage specializes in single-cell analysis transforming the life sciences. Our goal is to apply innovative computational methods to extract valuable insight from biological data, fueling cutting-edge research across biological disciplines. Our flagship product, the Biomage Single Cell Platform empowers researchers to take ownership of their single cell data analysis, generating deep biological insight in just a few clicks.
BiomeSense is developing the first technology platform for continuous, at-home monitoring of the human gut microbiome, transforming the ability to understand & utilize the microbiome for precision medicine. The enabling technology is the GutLab, the first “smart bathroom” system for at-home microbiome monitoring, which is combined with the MetaBiome time-series analytics platform into a single end-to-end solution. The platform allows scientists, patients, and consumers the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, revolutionizing the ability to leverage the microbiome for better health.
Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels.
Magellan Life Sciences develops proprietary protein engineering and expression platforms. These platforms are used to develop novel proteins for the food, health and nutrition sector.
Microgenesis offers a new fertility test and personalized nutritional supplementation that restores the fertility potential of women everywhere. Microgenesis has proven their validity in tough cases – women who have already failed multiple IVF implantations. Now, they are bringing their solution downmarket to OB-GYNs and D2C, operating out of a CLIA lab in Oakland. Microgenesis’ diagnostic detects subclinical inflammation that harms ovarian function and implantation. Their three-month treatment is drug-free and all-natural.
Intrinsic Medicine is a venture-backed, virtual, clinical-stage company with a technical and operational platform built to efficiently and ethically bring important medicines to patients.
Prolific Machines is a biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future. It combines cutting-edge technologies to enable cell production at a new scale. The company was founded in 2020 and is based in San Francisco, California.
Cybele Microbiome offers a proprietary platform that brings precision control to the microbiome. Its AI platform combines machine learning with cutting-edge biotechnology and proprietary data sources, to discover natural prebiotics that feeds the microbiome to make targeted natural solutions.
Cybele Microbiome offers a proprietary platform that brings precision control to the microbiome. Its AI platform combines machine learning with cutting-edge biotechnology and proprietary data sources, to discover natural prebiotics that feeds the microbiome to make targeted natural solutions.
Sun Genomics is a precision nutrition company focused on curing dysbiosis through the gut microflora and personalized solutions. Its flagship product Floré, is a microbiome test and custom synbiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product based on their unique gut profiles. The company also offers: Floré Tots, Kids, and Baby, available for kids up to age 0-12, and comes in an easy digestive powder to mix with their favorite drink. Floré Clinical, which is specifically for professional practitioners and their patients. Floré Defense, Balance, and Performance for sports teams and athletes.
Prolific Machines is a biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future. It combines cutting-edge technologies to enable cell production at a new scale. The company was founded in 2020 and is based in San Francisco, California.
Prolific Machines is a biotech company developing cell technologies to redefine how cells are produced for a sustainable and healthy future. It combines cutting-edge technologies to enable cell production at a new scale. The company was founded in 2020 and is based in San Francisco, California.
Biomage specializes in single-cell analysis transforming the life sciences. Our goal is to apply innovative computational methods to extract valuable insight from biological data, fueling cutting-edge research across biological disciplines. Our flagship product, the Biomage Single Cell Platform empowers researchers to take ownership of their single cell data analysis, generating deep biological insight in just a few clicks.
BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline of indications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
BioLumen is a nutritional technology company that develops a patented dietary fiber technology platform that reduces the negative effect of a diet heavy in processed foods. BioLumen's technology is composed of insoluble dietary fiber matrix covered with a blend of food ingredients created from the latest drug delivery system research. The company's product, a nutraceutical, focuses on high risk individuals with prediabetes to help manage blood sugar levels, protect their liver from excess sugar and feed their gut microbiome, delivering health benefits. BioLumen was founded on 2018 and is headquartered in San Francisco, California.
Sothic Bioscience Ltd. is a biotech company based in Cork, Ireland, established in 2015. The company focuses on developing LimuleX, a bio-production platform designed to create bio-identical replacements for naturally sourced limulus amebocyte lysate. This innovation aims to eliminate the reliance on the threatened horseshoe crab species in the pharmaceutical quality control supply chain. Sothic Bioscience is currently in the lab bench production phase of a highly specific pyrogen contamination testing reagent. To support scaling up production and market entry, the company is actively raising seed capital, emphasizing its commitment to replacing unsustainable animal sourcing with scalable production of high-quality biomolecules for the pharmaceutical, medical device, and biomedical research sectors.
MicroSynbiotiX engages in the development of a technology solution that eliminates the excessive use of antibiotics in farmed fish. With MicroSynbiotiX's advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. By using microalgae as an oral delivery vehicle, MicroSynbiotiX substantially cuts the labor and post-processing production costs, allowing the production of effective vaccines that are much more affordable and user-friendly. The technology can eliminate the use of antibiotics, reduce fish mortality rates in aquaculture farms, prevent bacterial and viral diseases from wiping out entire fish stocks, and improve global food security. MicroSynbiotiX was founded on 2016 and is headquartered in Cork City, Ireland.
Sun Genomics is a precision nutrition company focused on curing dysbiosis through the gut microflora and personalized solutions. Its flagship product Floré, is a microbiome test and custom synbiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product based on their unique gut profiles. The company also offers: Floré Tots, Kids, and Baby, available for kids up to age 0-12, and comes in an easy digestive powder to mix with their favorite drink. Floré Clinical, which is specifically for professional practitioners and their patients. Floré Defense, Balance, and Performance for sports teams and athletes.
Intrinsic Medicine is a venture-backed, virtual, clinical-stage company with a technical and operational platform built to efficiently and ethically bring important medicines to patients.
BiomeSense is developing the first technology platform for continuous, at-home monitoring of the human gut microbiome, transforming the ability to understand & utilize the microbiome for precision medicine. The enabling technology is the GutLab, the first “smart bathroom” system for at-home microbiome monitoring, which is combined with the MetaBiome time-series analytics platform into a single end-to-end solution. The platform allows scientists, patients, and consumers the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, revolutionizing the ability to leverage the microbiome for better health.
BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline of indications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
At Pando Nutrition, Inc. we are solving the antibiotic resistance crisis with genetically engineered probiotics that support livestock health and performance without the use of medically significant drugs.
Dahlia Biosciences is a biotechnology company based in California, founded in 2011. It focuses on DNA analysis and diagnostics, specializing in single-cell RNA analysis tools that are applicable for both research and diagnostic purposes. The company develops RNA detection tools utilizing CRISPR-Cas9 technology, which allows for the detection of multiple DNA and RNA biomarkers directly within cells and tissues. This innovative approach enables scientists to study and isolate cells with high precision and resolution, facilitating advancements in precision medicine research.
ZiO Health is a biotechnology company that has developed proprietary pocket-sized technology, bringing laboratory testing to the point-of-care to improve patient outcomes. Using ZiO Health's proprietary biosensor technology & machine learning algorithms we combine real-time results with the patients unique profile to enhance patient care.
Microendo operates to protect and care for the environment. Environmental damage due to climate change poses a great risk to crop security. By harnessing the natural microbiota of the plants they develop products that are in harmony with the environment. They take the microorganisms from your own plants, identify their needs and provide you with a tailored biofertilizer. This biofertilizer is personalized to each crop, fully organic and naturally helps to increase crop health & crop yield.
BiomeSense is developing the first technology platform for continuous, at-home monitoring of the human gut microbiome, transforming the ability to understand & utilize the microbiome for precision medicine. The enabling technology is the GutLab, the first “smart bathroom” system for at-home microbiome monitoring, which is combined with the MetaBiome time-series analytics platform into a single end-to-end solution. The platform allows scientists, patients, and consumers the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, revolutionizing the ability to leverage the microbiome for better health.
Sun Genomics is a precision nutrition company focused on curing dysbiosis through the gut microflora and personalized solutions. Its flagship product Floré, is a microbiome test and custom synbiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product based on their unique gut profiles. The company also offers: Floré Tots, Kids, and Baby, available for kids up to age 0-12, and comes in an easy digestive powder to mix with their favorite drink. Floré Clinical, which is specifically for professional practitioners and their patients. Floré Defense, Balance, and Performance for sports teams and athletes.
Biospin is an introducing a revolutionary microbial detection system that provides gold standard detection of pathogens for F&B, water, consumer goods and pharmaceutical products in real time.
MicroSynbiotiX engages in the development of a technology solution that eliminates the excessive use of antibiotics in farmed fish. With MicroSynbiotiX's advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. By using microalgae as an oral delivery vehicle, MicroSynbiotiX substantially cuts the labor and post-processing production costs, allowing the production of effective vaccines that are much more affordable and user-friendly. The technology can eliminate the use of antibiotics, reduce fish mortality rates in aquaculture farms, prevent bacterial and viral diseases from wiping out entire fish stocks, and improve global food security. MicroSynbiotiX was founded on 2016 and is headquartered in Cork City, Ireland.
Dahlia Biosciences is a biotechnology company based in California, founded in 2011. It focuses on DNA analysis and diagnostics, specializing in single-cell RNA analysis tools that are applicable for both research and diagnostic purposes. The company develops RNA detection tools utilizing CRISPR-Cas9 technology, which allows for the detection of multiple DNA and RNA biomarkers directly within cells and tissues. This innovative approach enables scientists to study and isolate cells with high precision and resolution, facilitating advancements in precision medicine research.
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources.
Biomathematica is a biotech start-up providing a high level modeling service to characterize and understand a biological process, simulate, monitor, control, optimize and modify its behavior. Biomathematica has developed innovative genome-scale metabolic models to answer your questions and improve your business: from genome to microbiome, from genome to cell interactions.
ZiO Health is a biotechnology company that has developed proprietary pocket-sized technology, bringing laboratory testing to the point-of-care to improve patient outcomes. Using ZiO Health's proprietary biosensor technology & machine learning algorithms we combine real-time results with the patients unique profile to enhance patient care.
Fuelling the onset of personalised medicine with our cell isolation tools. Our tools allows researchers, in academia and industry, non-invasive, on-demand and remote access to an individual’s cells, at an unprecedented scale.
Magellan Life Sciences develops proprietary protein engineering and expression platforms. These platforms are used to develop novel proteins for the food, health and nutrition sector.
Sun Genomics is a precision nutrition company focused on curing dysbiosis through the gut microflora and personalized solutions. Its flagship product Floré, is a microbiome test and custom synbiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product based on their unique gut profiles. The company also offers: Floré Tots, Kids, and Baby, available for kids up to age 0-12, and comes in an easy digestive powder to mix with their favorite drink. Floré Clinical, which is specifically for professional practitioners and their patients. Floré Defense, Balance, and Performance for sports teams and athletes.
Dahlia Biosciences is a biotechnology company based in California, founded in 2011. It focuses on DNA analysis and diagnostics, specializing in single-cell RNA analysis tools that are applicable for both research and diagnostic purposes. The company develops RNA detection tools utilizing CRISPR-Cas9 technology, which allows for the detection of multiple DNA and RNA biomarkers directly within cells and tissues. This innovative approach enables scientists to study and isolate cells with high precision and resolution, facilitating advancements in precision medicine research.
Scaled Biolabs is pioneering a Cell Therapy Discovery Engine, working at the frontier of microfluidics, automation, and machine learning to develop best-in-class cell-based medicines. This engine enables leading biotech and pharma companies to survey hundreds of parameters across tens of thousands of experimental processes, providing an unprecedented window into cell-driven biology. This enables the development of novel and optimal cell-based products and processes, simplifying manufacturing, reducing time to market, and improving clinical outcomes. Scaled Biolabs also develops cell therapy assets internally, including a CIRM-funded program focusing on iPSC-derived dopaminergic neurons as a curative cell therapy for Parkinson’s disease.
MicroSynbiotiX engages in the development of a technology solution that eliminates the excessive use of antibiotics in farmed fish. With MicroSynbiotiX's advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. By using microalgae as an oral delivery vehicle, MicroSynbiotiX substantially cuts the labor and post-processing production costs, allowing the production of effective vaccines that are much more affordable and user-friendly. The technology can eliminate the use of antibiotics, reduce fish mortality rates in aquaculture farms, prevent bacterial and viral diseases from wiping out entire fish stocks, and improve global food security. MicroSynbiotiX was founded on 2016 and is headquartered in Cork City, Ireland.
We’re a bioengineering company that's reducing the massive environmental footprint of the CBD market through precision fermentation. And our technology never touches a plant. CBD is a global $12Bn consumer market and Hyasynth's precision fermentation platform eliminates wasteful plant cultivation and decreases the carbon impact by more than 97%. Hyasynth is the world's only bioengineering company with a scalable, fermentation process for CBD that is cost-efficient and regulatory-compliant.
ZiO Health is a biotechnology company that has developed proprietary pocket-sized technology, bringing laboratory testing to the point-of-care to improve patient outcomes. Using ZiO Health's proprietary biosensor technology & machine learning algorithms we combine real-time results with the patients unique profile to enhance patient care.
OneSkin is a longevity company on a mission to extend the health of your skin and body. Founded by a team of four PhDs and longevity scientists, they have identified a novel proprietary peptide, OS-01, which is the first compound validated to reduce your skin's biological age by decreasing the accumulation of aged cells, improving cellular repair capacity and strengthening the epidermal skin barrier. Their flagship product, OS-01 Topical Supplement is currently available through their website.
SwaLife Biotech discovers small molecules from plants for cosmetics and synthesizes novel anticancer plant alkaloids for medical use targeting DNA damage response.
Kaitek Labs is a research and development, and biotechnology company specialized in the design and production of biosensors. It was founded by Emilia Díaz in 2013 and is based in Chile.
ZiO Health is a biotechnology company that has developed proprietary pocket-sized technology, bringing laboratory testing to the point-of-care to improve patient outcomes. Using ZiO Health's proprietary biosensor technology & machine learning algorithms we combine real-time results with the patients unique profile to enhance patient care.
We’re a bioengineering company that's reducing the massive environmental footprint of the CBD market through precision fermentation. And our technology never touches a plant. CBD is a global $12Bn consumer market and Hyasynth's precision fermentation platform eliminates wasteful plant cultivation and decreases the carbon impact by more than 97%. Hyasynth is the world's only bioengineering company with a scalable, fermentation process for CBD that is cost-efficient and regulatory-compliant.
MicroSynbiotiX engages in the development of a technology solution that eliminates the excessive use of antibiotics in farmed fish. With MicroSynbiotiX's advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. By using microalgae as an oral delivery vehicle, MicroSynbiotiX substantially cuts the labor and post-processing production costs, allowing the production of effective vaccines that are much more affordable and user-friendly. The technology can eliminate the use of antibiotics, reduce fish mortality rates in aquaculture farms, prevent bacterial and viral diseases from wiping out entire fish stocks, and improve global food security. MicroSynbiotiX was founded on 2016 and is headquartered in Cork City, Ireland.
Scaled Biolabs is pioneering a Cell Therapy Discovery Engine, working at the frontier of microfluidics, automation, and machine learning to develop best-in-class cell-based medicines. This engine enables leading biotech and pharma companies to survey hundreds of parameters across tens of thousands of experimental processes, providing an unprecedented window into cell-driven biology. This enables the development of novel and optimal cell-based products and processes, simplifying manufacturing, reducing time to market, and improving clinical outcomes. Scaled Biolabs also develops cell therapy assets internally, including a CIRM-funded program focusing on iPSC-derived dopaminergic neurons as a curative cell therapy for Parkinson’s disease.
Pure Cultures is an artisan facility providing custom probiotic strains for clients nationwide. It is dedicated to producing products that add health benefits and help solve issues related to the stresses of their industrial economy. They are experts in the development of products for both human and animal health. The company's single and multiple probiotic blends are tailored to meet each client’s unique needs. They are a custom fermentation company employing a range of reactors to produce proprietary probiotic strains. They provide custom silage inoculation blends starting with orders as small as 1.0kg quantities. Their fermentation capabilities range from bench-top to large-scale. The fermentation process incorporates cutting-edge technology in media development and selection, and in the harvesting and preservation of probiotic cultures. They partner with their clients from idea to commercialization and excel at fulfilling short lead times. Pure Cultures specializes in strain-specific research and development and can provide general technical expertise on new probiotic delivery methods and new formula combinations. They are experts in fermentation research, product formulation, and new product development.
BlueTurtleBio Technologies creates a next generation therapeutic using a patent pending platform technology. The company's mission is the golden triangle of healthcare: safety, effectiveness and affordability. Most healthcare options miss one or more of these standards. At Blue Turtle, they plan to recruit a genetically malleable and easily replenishable organ in the human body: the microbiome.
Scaled Biolabs is pioneering a Cell Therapy Discovery Engine, working at the frontier of microfluidics, automation, and machine learning to develop best-in-class cell-based medicines. This engine enables leading biotech and pharma companies to survey hundreds of parameters across tens of thousands of experimental processes, providing an unprecedented window into cell-driven biology. This enables the development of novel and optimal cell-based products and processes, simplifying manufacturing, reducing time to market, and improving clinical outcomes. Scaled Biolabs also develops cell therapy assets internally, including a CIRM-funded program focusing on iPSC-derived dopaminergic neurons as a curative cell therapy for Parkinson’s disease.
Cell Reserves Inc. is a Canadian biopharmaceutical company based in Ottawa, specializing in the development of protein and peptide-based therapeutics aimed at treating autoimmune diseases and reducing excessive inflammation. The company employs innovative molecular shields that enhance the bioavailability and longevity of these therapies in the body, ultimately aiming to improve treatment outcomes and lower the associated risks and costs of disease management. By focusing on increasing the persistency of therapeutics in circulation, Cell Reserves also explores possibilities for oral and nasal delivery methods and seeks to expand its applications to include improved vaccines.
Sothic Bioscience Ltd. is a biotech company based in Cork, Ireland, established in 2015. The company focuses on developing LimuleX, a bio-production platform designed to create bio-identical replacements for naturally sourced limulus amebocyte lysate. This innovation aims to eliminate the reliance on the threatened horseshoe crab species in the pharmaceutical quality control supply chain. Sothic Bioscience is currently in the lab bench production phase of a highly specific pyrogen contamination testing reagent. To support scaling up production and market entry, the company is actively raising seed capital, emphasizing its commitment to replacing unsustainable animal sourcing with scalable production of high-quality biomolecules for the pharmaceutical, medical device, and biomedical research sectors.
MicroSynbiotiX engages in the development of a technology solution that eliminates the excessive use of antibiotics in farmed fish. With MicroSynbiotiX's advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. By using microalgae as an oral delivery vehicle, MicroSynbiotiX substantially cuts the labor and post-processing production costs, allowing the production of effective vaccines that are much more affordable and user-friendly. The technology can eliminate the use of antibiotics, reduce fish mortality rates in aquaculture farms, prevent bacterial and viral diseases from wiping out entire fish stocks, and improve global food security. MicroSynbiotiX was founded on 2016 and is headquartered in Cork City, Ireland.
Magenta Biolabs transforms organic by-products into high quality raw material for cosmetic industry. They are exploiting the potencial of many industrial and agricultural nutrient-rich by-products, to recycle the nutrients and transform them into hyaluronic acid and many different highly valued molecules.
OneSkin is a longevity company on a mission to extend the health of your skin and body. Founded by a team of four PhDs and longevity scientists, they have identified a novel proprietary peptide, OS-01, which is the first compound validated to reduce your skin's biological age by decreasing the accumulation of aged cells, improving cellular repair capacity and strengthening the epidermal skin barrier. Their flagship product, OS-01 Topical Supplement is currently available through their website.
Amaryllis Nucleics is a Bay Area-based start-up company focused on proprietary RNA Sequencing methods. It has been providing customers an end-to-end solution with shorter turn-around times from RNA to library prep with complete data analysis at a lower cost per sample compared to whole transcriptome sequencing approaches for RNASeq.
At DtoR they have developed the PCR of gene expression—a disruptive technology that will revolutionize the tools used to “tune” protein production in any organism. In one step, and for any cell type, they can identify all of the switches regulating expression of the genome, as well as how active they are. They can also rapidly evolve or synthesize new switches to adapt to any application. Applications developed using their platform will lead to improved product yields in bioreactors, engineered specialty crops, optimized cancer therapeutics, and much more. The possibilities are limited only by their partners' imaginations.
We’re a bioengineering company that's reducing the massive environmental footprint of the CBD market through precision fermentation. And our technology never touches a plant. CBD is a global $12Bn consumer market and Hyasynth's precision fermentation platform eliminates wasteful plant cultivation and decreases the carbon impact by more than 97%. Hyasynth is the world's only bioengineering company with a scalable, fermentation process for CBD that is cost-efficient and regulatory-compliant.
Sothic Bioscience Ltd. is a biotech company based in Cork, Ireland, established in 2015. The company focuses on developing LimuleX, a bio-production platform designed to create bio-identical replacements for naturally sourced limulus amebocyte lysate. This innovation aims to eliminate the reliance on the threatened horseshoe crab species in the pharmaceutical quality control supply chain. Sothic Bioscience is currently in the lab bench production phase of a highly specific pyrogen contamination testing reagent. To support scaling up production and market entry, the company is actively raising seed capital, emphasizing its commitment to replacing unsustainable animal sourcing with scalable production of high-quality biomolecules for the pharmaceutical, medical device, and biomedical research sectors.
Zymochem provides a carbon-efficient bio-manufacturing platform that converts renewable feedstocks into bio-based materials without compromising price, performance, scale, or sustainability while minimizing CO2 loss during production. It also accelerates a real-zero economy by relieving carbon emissions in product development, use, and end-of-life.
Arcturus BioCloud is a virtual bio-foundry for rapid prototyping microorganisms using genetic engineering. They’ve simplified the outsourcing of experiments on and yeast by seamlessly integrating genetic engineering technologies into a user-friendly platform that covers the whole genetic engineering cycle. Users can upload on Arcturus BioCloud their biological design, and they will build and test it for them. This way, helping organisations accelerate their process of developing innovative products. For that, they already have in place partnerships with Synbiota and ZymoResearch that provide us with advance technologies. In the following months, they will be adding new partnerships to extend their service portfolio. Their mission is to make more accessible these technologies so that scientists from all around the world can work with the best tools, regardless of their geographical limitations. They also have a great team; they met at Singularity University, and they cover all the domains required for executing the mission. Biotechnology is one of the fastest-growing markets, mainly because of the exponential price reduction of Synthesizing and Sequencing, which is beating Moore’s Law. As the prices decrease, more people will start to create innovations and companies. They see this future very close, and that is why they’ve started providing these technologies that in the following years will be 100x cheaper.
BlueTurtleBio Technologies creates a next generation therapeutic using a patent pending platform technology. The company's mission is the golden triangle of healthcare: safety, effectiveness and affordability. Most healthcare options miss one or more of these standards. At Blue Turtle, they plan to recruit a genetically malleable and easily replenishable organ in the human body: the microbiome.
Extem is a group of scientists and engineers that have watched our idea blossom into a business. Their process focuses on isolating and expanding large numbers of mesenchymal stem cells in order to provide researchers with a consistent, reliable product. They aim to help advance the stem cell field. It is their belief that MSCs are the solution for many patients whose conditions prevent them from living their life to the fullest. Whether its a torn meniscus, or a fractured bone, recent findings suggest that biomaterials can provide a permanent, functional solution.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.